Helix BioPharma Corp (HBPCF)
0.1377
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Helix BioPharma Total Assets (Quarterly): 1.370M for Oct. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2023 | 1.370M |
| July 31, 2023 | 0.7763M |
| April 30, 2023 | 1.162M |
| January 31, 2023 | 2.388M |
| October 31, 2022 | 3.528M |
| July 31, 2022 | 2.878M |
| April 30, 2022 | 1.804M |
| January 31, 2022 | 0.7397M |
| October 31, 2021 | 1.866M |
| July 31, 2021 | 3.258M |
| April 30, 2021 | 2.462M |
| January 31, 2021 | 3.912M |
| October 31, 2020 | 3.436M |
| July 31, 2020 | 3.657M |
| April 30, 2020 | 3.973M |
| January 31, 2020 | 2.073M |
| October 31, 2019 | 1.849M |
| July 31, 2019 | 0.7149M |
| April 30, 2019 | 1.188M |
| January 31, 2019 | 0.909M |
| October 31, 2018 | 1.357M |
| July 31, 2018 | 0.8803M |
| April 30, 2018 | 1.334M |
| January 31, 2018 | 2.150M |
| October 31, 2017 | 3.192M |
| Date | Value |
|---|---|
| July 31, 2017 | 1.755M |
| April 30, 2017 | 1.664M |
| January 31, 2017 | 1.902M |
| October 31, 2016 | 2.421M |
| July 31, 2016 | 3.397M |
| April 30, 2016 | 4.447M |
| January 31, 2016 | 2.330M |
| October 31, 2015 | 4.324M |
| July 31, 2015 | 5.993M |
| April 30, 2015 | 8.314M |
| January 31, 2015 | 2.823M |
| October 31, 2014 | 4.994M |
| July 31, 2014 | 7.198M |
| April 30, 2014 | 3.343M |
| January 31, 2014 | 4.945M |
| October 31, 2013 | 3.520M |
| July 31, 2013 | 5.695M |
| April 30, 2013 | 8.055M |
| January 31, 2013 | 10.24M |
| October 31, 2012 | 5.829M |
| July 31, 2012 | 7.602M |
| April 30, 2012 | 10.19M |
| January 31, 2012 | 15.98M |
| October 31, 2011 | 21.84M |
| July 31, 2011 | 25.66M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.7149M
Minimum
Jul 2019
3.973M
Maximum
Apr 2020
2.265M
Average
2.073M
Median
Jan 2020
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 964.80M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.9205M |
| Shareholders Equity (Quarterly) | 0.4498M |